Pinto F - Search Results

1

A circulating miRNA assay as a first-line test for prostate cancer screening.

Sharova E, Grassi A, Marcer A, Ruggero K, Pinto F, Bassi P, Zanovello P, Zattoni F, D'Agostino DM, Iafrate M, Ciminale V. Sharova E, et al. Among authors: pinto f. Br J Cancer. 2016 Jun 14;114(12):1362-6. doi: 10.1038/bjc.2016.151. Epub 2016 May 26. Br J Cancer. 2016. PMID: 27228285 Free PMC article.

2

Plasma chromogranin A in patients with prostate cancer improves the diagnostic efficacy of free/total prostate-specific antigen determination.

Fracalanza S, Prayer-Galetti T, Pinto F, Navaglia F, Sacco E, Ciaccia M, Plebani M, Pagano F, Basso D. Fracalanza S, et al. Among authors: pinto f. Urol Int. 2005;75(1):57-61. doi: 10.1159/000085929. Urol Int. 2005. PMID: 16037709

3

Non-invasive diagnostic tests for bladder cancer: a review of the literature.

Bassi P, De Marco V, De Lisa A, Mancini M, Pinto F, Bertoloni R, Longo F. Bassi P, et al. Among authors: pinto f. Urol Int. 2005;75(3):193-200. doi: 10.1159/000087792. Urol Int. 2005. PMID: 16215303 Review.

4

Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guérin therapy.

Bassi P, De Marco V, Tavolini IM, Longo F, Pinto F, Zucchetti M, Crucitta E, Marini L, Dal Moro F. Bassi P, et al. Among authors: pinto f. Urol Int. 2005;75(4):309-13. doi: 10.1159/000089164. Urol Int. 2005. PMID: 16327296 Clinical Trial.

5

[Transitional cell carcinoma involvement of the prostate].

Bassi P, De Lisa A, Usai P, Pinto F, Sacco E. Bassi P, et al. Among authors: pinto f. Ann Urol (Paris). 2005 Nov;39 Suppl 5:S113-9. Ann Urol (Paris). 2005. PMID: 16425728 Review. French.

6

Emerging pharmacological targets in overactive bladder therapy: experimental and clinical evidences.

Sacco E, Pinto F, Bassi P. Sacco E, et al. Among authors: pinto f. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Apr;19(4):583-98. doi: 10.1007/s00192-007-0529-z. Epub 2008 Jan 15. Int Urogynecol J Pelvic Floor Dysfunct. 2008. PMID: 18196198 Review.

7

Inhibition of prostate efferent neurotransmission by amikacin.

Gardi M, Nigro F, Ragazzi E, Sacco E, Volpe A, Totaro A, Pinto F, Bassi P. Gardi M, et al. Among authors: pinto f. Prostate. 2008 Sep 1;68(12):1330-5. doi: 10.1002/pros.20802. Prostate. 2008. PMID: 18512731

8

In vitro effect of amikacin on rat and human detrusor muscle contraction.

Gardi M, Nigro F, Ragazzi E, Volpe A, Totaro A, Sacco E, Pinto F, Bassi P. Gardi M, et al. Among authors: pinto f. Urol Int. 2008;81(1):94-100. doi: 10.1159/000137648. Epub 2008 Jul 16. Urol Int. 2008. PMID: 18645279

9

Bladder tumor markers: a review of the literature.

Volpe A, Racioppi M, D'Agostino D, Cappa E, Gardi M, Totaro A, Pinto F, Sacco E, Marangi F, Palermo G, Bassi PF. Volpe A, et al. Among authors: pinto f. Int J Biol Markers. 2008 Oct-Dec;23(4):249-61. doi: 10.1177/172460080802300409. Int J Biol Markers. 2008. PMID: 19199274 Free article. Review.

10

New therapeutical approaches for non muscle invasive bladder cancer.

Volpe A, Racioppi M, Sacco E, Bongiovanni L, D'Agostino D, Cappa E, Pinto F, Gardi M, Totaro A, Bassi P. Volpe A, et al. Among authors: pinto f. Arch Ital Urol Androl. 2008 Dec;80(4):136-42. Arch Ital Urol Androl. 2008. PMID: 19235429 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,864 results

Search Page

Filters